Heart size and function in children with single right ventricle (RV) anomalies may be influenced by shunt type at the Norwood procedure. We sought to identify shunt-related differences during early childhood after staged surgical palliations using echocardiography.
Frommelt et al; Echocardiographic Indices at 6 Years-the SVR Trial
The optimal strategy for initial surgical palliation of hypoplastic left heart syndrome and other single right ventricle (RV) anomalies remains unclear. The Pediatric Heart Network 1 SVR trial (Single Ventricle Reconstruction) compared outcomes in 549 infants undergoing a Norwood procedure for single RV anomalies randomly assigned to either a modified Blalock-Taussig shunt (MBTS) or RV-to-pulmonary-artery shunt (RVPAS) at 15 North American centers. 2 Although better 1-year transplant-free survival was found for those who received an RVPAS compared with those who had an MBTS, 3 the survivor benefit was no longer statistically significant at 3 4 and 6 years 5 of age. Similarly, the early advantage seen in RV systolic function diminished over time. Specifically, RV ejection fraction (RVEF) was better early after Norwood palliation in those who received an RVPAS but had become similar between the shunt groups at 14 months after shunt removal and stage II palliation. 6 By 3 years of age, RVEF was significantly worse in the RVPAS compared with the MBTS. 7 These observations suggested that important differences between the shunt groups might emerge with longer term follow-up.
The Pediatric Heart Network SVR Extension Study was undertaken to provide longitudinal surveillance of the cohort, including echocardiography within 6 months of Fontan palliation 7 and at 6 years of age. In this analysis, we compared 2-dimensional and Doppler indices of RV size and function, as well as neoaortic and tricuspid valve annulus dimensions and function, between shunt groups at 14 months of age, before the Fontan procedure, and at 6 years. We investigated within-patient changes over time in these measures and sought to identify echocardiographic RV systolic indices at 14 months that might predict clinical outcomes at latest follow-up.
METHODS
The data, analytic methods, and study materials will be/have been made available to other researchers for purposes of reproducing the results or replicating the procedure. The public use dataset for the SVR trial is available on the public website: http://www.pediatricheartnetwork.org/ForResearchers/ PHNPublicUseDatasets.aspx. We anticipate that the SVR Extension trial datasets will be available for public use at the same website in the next 12 months.
Subjects
The entry criteria for the SVR trial 2 have been reported previously. In the current study, we included SVR trial survivors who, within 1 year of their sixth birthday, underwent a transthoracic echocardiogram that was submitted to the SVR core echocardiography laboratory for interpretation. We excluded subjects who underwent cardiac transplantation (n=44), biventricular repair (n=3), or did not consent to the SVR extension trial (n=34). The study was approved by an institutional review board at each clinical site where the echocardiographic studies were performed, and the participants' parents gave written informed consent.
Study Design
Earlier publications have described the SVR study design 2 and outcomes at ages of 12 months, 3, [8] [9] [10] 3 years, 4 and 6 years 5, 11, 12 after randomization. We have also characterized echocardiographic markers of outcome for the SVR trial, including 14-month 6 and pre-Fontan 7 indices of RV function, cardiac and vascular dimensions, valve annulus dimensions and function, and neoaortic flow patterns 13 in previous publications.
Echocardiographic Analysis
An echocardiography core laboratory at the Medical College of Wisconsin reviewed 2-dimensional/Doppler echocardiograms performed at each clinical center within 1 year of a subject's sixth birth date. The echocardiogram was performed at SVR-designated clinical sites when possible but also could be performed under the supervision of the local primary cardiologist. Core lab procedures for image analysis and data management have been described previously. 6, 7 Echocardiographic measures are summarized in Tables I and  II in the Data Supplement. The core laboratory was blinded to the initial shunt type once the shunt was removed at the stage II operation for all 14-month, pre-Fontan, and 6-year echocardiograms. ) to the 6-year study, as well as from the pre-Fontan study 7 to the 6-year study when protocol echocardiograms were available within the respective time periods. Comparisons of variables were paired, that is, within subject, and only subjects who were alive at 6 years were included in the analyses of changes over time. We also performed a longitudinal analysis across all 3 time points among subjects with an echo at 6 years, using repeated-measures ANOVA for continuous measures and Fisher exact tests for categorical measures. Study inferences were similar using both methods. Finally, we performed Cox regression analyses, conditional on survival to the 14-month echocardiogram (time 0), to explore the associations of RVEF and RV percentage fractional area change (FAC) at 14 months with transplant-free survival using all available data. In all analyses, a P ≤0.05 was accepted for statistical significance. No formal adjustment was made for multiple testing because many of the echo indices are correlated. If all 26 were independent, one would expect 1 to 2 significant comparisons because of chance alone. However, many variables were not independent, and the degree of correlation among echocardiographic parameters is highly variable. Therefore, we did not adjust for multiple testing. Rather, based on the principle in the American Statistical Association statement on P values, we report the number of hypotheses explored during the study, all data collection decisions, all statistical analyses conducted, and all P values computed.
Statistical Analysis
14 Analyses were performed in SAS, version 9.4 (SAS Institute, Cary, NC).
To adjust for the effect of somatic growth and age on the linear, area, and volumetric dimensions of cardiac structures and Doppler flow patterns, Z scores relative to body surface area were used when normative data were available. 15 Z scores from the normal RV in a biventricular circulation were used for these comparisons. The dimensions of the neoaortic valve annulus were expressed as Z scores using normal values for the dimensions of the native aortic valve in a normal population.
All core lab echocardiographic parameters were measured by a single dedicated pediatric sonographer trained in pediatric echocardiography and confirmed by a single experienced pediatric echocardiographer. Reproducibility of echocardiographic measurements has been previously published for the SVR trial using this core laboratory with good intraclass correlations and percentage agreement for continuous and dichotomous variables.
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RESULTS
Of the 269 SVR survivors who had research protocol echocardiographic studies submitted as part of their 6-year assessment, 241 (90%; 116 MBTS and 125 RVPAS) were acceptable for core lab analysis. The mean age at the time of 6-year echocardiogram was 71.1 months (2 subjects were >1 year past their sixth birthday at the time of the echocardiogram). Among the 241 subjects, 208 (86%; 102 MBTS and 125 RVPAS) had also undergone a pre-Fontan echocardiogram at a mean age of 34.3±10. 4 
Echocardiographic Assessment
RV Systolic Size and Function
At the 6-year echocardiogram, shunt types were similar with respect to all RV indices of size and systolic function, including RV indexed systolic volume, RVEF, indexed systolic area, FAC, and peak tricuspid annular systolic velocity (Table 1 ). In the overall cohort, at the 6-year compared with the pre-Fontan study, RV systolic volumes and indexed areas decreased significantly, and RVEF, FAC, and peak tricuspid annular systolic velocity increased significantly (Table 2) . When compared with the 14-month studies for the entire cohort, 6-year RV systolic volume was also significantly decreased (P=0.006), peak tricuspid annular systolic velocity increased (P<0.001), and RVEF increased nonsignificantly (P=0.06), but RV indexed areas and FAC were similar between those stages ( Table 3 ). The change in RVEF and FAC over time for the cohort is summarized in Figure 1 . In the combined cohort, there was no significant difference in the percentage of subjects who had an RVEF <40% at 14 months of age compared with 6 years of age (21.6% versus 20.5%; P>0.99). When comparing interval changes in measures between pre-Fontan and 6 years by assigned shunt group, RVEF (+3.90 for the RVPAS versus +0.10 for the MBTS; P=0.015) and FAC both significantly increased in the RVPAS compared with the MBTS group ( Figure 2 ; Table III in the Data Supplement). No other significant changes in systolic indices were identified from the preFontan study to 6 years, and all systolic indices were similar for both shunt groups when comparing the 14-month and 6-year echocardiograms (Table IV in the Data Supplement).
RV Diastolic Size and Function
At the 6-year echocardiogram, all diastolic indices were similar between the shunt groups. These included RV indexed end-diastolic volume, indexed enddiastolic area, RV sphericity index, tricuspid peak E and A velocities and E/A ratio, tricuspid annular E′ and A′ velocities, E/E′ ratio, and presence of pulmonary vein flow reversal during atrial systole ( Table 1 ). The presence of pulmonary vein flow reversal with atrial systole was rarely identified in either group (4.1% in MBTS versus 6.2% in RVPAS; P=0.55). The shunt groups were combined, and again comparisons were made between the pre-Fontan and 6-year exams ( Ta-4 Frommelt et al; Echocardiographic Indices at 6 Years-the SVR Trial ble 2). At 6 years, there was a significant decrease in RV indexed end-diastolic volumes and areas (Figure 3 ), an increase in E velocities and E′ velocities with a decrease in A and A′ velocities, and a resultant increased E/A ratio. Similar changes in diastolic indices occurred between the 14-month and 6-year echocardiograms (Table 3) . When comparing interval changes between shunt groups at the pre-Fontan and 6-year studies, the MBTS group had a significant increase in E′ velocities that was not seen in the RVPAS group, whereas the RVPAS had a significant decrease in the A′ velocities not seen in the MBTS (Table III in the Data Supplement) . The same analysis was done looking at interval change between 14 months and 6 years, stratified by shunt type, and there were no significant differences (Table IV in the Data Supplement).
RV Global Function
The myocardial performance index, as assessed by both blood flow Doppler and annular Doppler tissue imaging, was not significantly different between the shunt groups at the 6-year study (Table 1 ). In addition, there was no significant change in the index as calculated by either method from the pre-Fontan study to 6 years for entire cohort (Table 2 ). There was a significant increase in myocardial performance index as calculated by blood flow Doppler (0.48±0.19 versus 0.42±0.16; P=0.002) from the 14-month to the 6-year study echocardiogram for the entire cohort that was not seen when calculated by annular Doppler (Table 3) . When comparing interval changes between shunt groups pre-Fontan and at 6 years, the MBTS group had a significant increase in myocardial performance index by blood flow Doppler that was not seen in the RVPAS group (Table III in the Data  Supplement) ; no changes in myocardial performance index by either method were seen between shunt groups from the 14-month to 6-year study (Table IV in the Data Supplement).
Neoaortic Valve Size and Function
Indexed neoaortic annular areas were larger in the MBTS group compared with the RVPAS group at the 6-year study, with marked neoaortic annular dilatation in both groups, as evidenced by mean Z scores of 6.4±3.4 for MBTS versus 5.4±2.8 for RVPAS (P=0.04; Table 1 ). At 6 years, >mild regurgitation was rare and similar between groups (6.9% of the MBTS and 6.5% of the RVPAS; P=0.4), and no subject had severe regurgitation. Indexed neoaortic valve areas were similar at the pre-Fontan and 6-year studies for the entire cohort (Table 2 ) and decreased significantly between 14 months and 6 years ( Figure 4 ; Table 3 ). No differences were noted between the shunt groups when comparing 14-month (Table IV in the Data Supplement) and pre-Fontan studies (Table III in the Data Supplement) with measures at 6 years. The degree of neoaortic regurgitation was similar in the 2 groups and did not vary significantly between time points.
Tricuspid Valve Size and Function
Indexed tricuspid annular areas and Z scores were similar with mild annular dilatation in both groups at the 6-year study as evidenced by mean Z scores of 2.3±1.8 (Table 2) , in contrast to the significant decrease seen in both indexed areas and Z scores from 14 months to 6 years, with Z scores approaching normal in both groups at 6 years ( Figure 4 ; Table 3 ). The degree of change over time was similar for both shunt groups when comparing the 6-year study with the pre-Fontan (Table III in the Data Supplement) and 14-month studies (Table IV in the Data Supplement). The degree of tricuspid regurgitation was also stable and similar for the 2 groups at all time intervals.
Aortic Size and Patency
The ascending aortic diameter was similar in both shunt groups at the 6-year study with mild ascending aortic dilatation, as evidenced by mean Z scores of 3.1±2.4 for MBTS and 2.9±2.7 for RVPAS (P=0.57; Table 1 ). Absolute values for the ascending aorta increased from the pre-Fontan to 6-year study for the entire cohort, but Z scores were similar. The size of the ascending aorta was not recorded at the 14-month study, so information about that interval change was not available. The average peak velocity through the distal aortic arch was similar between the shunt groups at the 6-year study (1.8±0.5 for MBTS versus 1.8±0.5 m/s for RVPAS; P=0.43). In the overall cohort, the peak velocity was stable when compared with the pre-Fontan assessment, with average peak velocities <2 m/s for both groups at both intervals ( Table 2) . A statistically significant increase in peak velocity was found at the 6-year compared with the 14-month study, but this difference was clinically insignificant (1.81±0.52 at 6 years versus 1.68±0.54 at 14 months; P=0.001; Table 3 ). The shunt groups did not vary in the distal arch velocities over time (Tables III and IV in the Data Supplement).
RV Systolic Function and Transplant-Free Survival
The 14-month RVEF and RV FAC values were evaluated for their relationship to late death/transplant using a conditional analysis (with time zero equal to 14 months). There were 43 deaths/transplants in the 337 subjects (13%) who had 14-month echocardiograms. RVEF was evaluated both as a continuous variable and as a categorical variable (<40% versus ≥40%). In both models, decreased RVEF at 14 months was predictive of late outcome (both P=0.03). When RVEF was <40%, the hazard ratio for death/transplant was 3. Frommelt et al; Echocardiographic Indices at 6 Years-the SVR Trial
DISCUSSION
The SVR trial sought to answer a critical question in surgical management of infants with single RV anomalies undergoing a Norwood procedure: which shunt (the RVPAS or MBTS) was associated with better clinical outcomes? After 6 years of longitudinal follow-up, that answer remains unclear. Better transplant-free survival at 1 year in the SVR cohort 3 was not sustained at 3 years, when the RVPAS group had lower RVEF 7 and more frequent catheter-based interventions. 4 This report summarizing the echocardiographic characteristics of the SVR cohort at 6 years continues to add to the longitudinal assessment of this unique population and supports the notion that neither shunt is unequivocally superior, with no shunt-related survivor benefit at 6 years of age. 5 Specifically, among transplant-free survivors at 6 years, we found that initial shunt type did not significantly impact echocardiographic indices of RV, neoaortic, and tricuspid valve size and function. Overall, these data suggest that there is beneficial remodeling of RV size, systolic and diastolic function, and neoaortic and tricuspid valve size over time in this cohort, regardless of shunt type.
The last report summarizing echocardiographic findings for the SVR cohort was based on observations from serial studies collected during infancy, at 14 months, and before Fontan palliation. 7 Most con- There was a significant increase in both the ejection fraction and fractional area change from the pre-Fontan to the 6-y echocardiogram. There was a trend toward increased right ventricular ejection fraction from 14 mo to 6 y (P=0.06), but fractional area change was similar between those stages. cerning was the finding that, before Fontan, RVEF was worse in the RVPAS group compared with the MBTS-a finding that was supported by other investigations [16] [17] [18] [19] showing poorer RV function after RVPAS. In the current study using paired echocardiograms, we did not see further decline in RVEF from the pre-Fontan to the 6-year exam, suggesting a period of stable RV function early after Fontan palliation. Despite concerns that the ventriculotomy required for the RVPAS could result in myocardial injury/scarring that would eventually affect ventricular performance, 20, 21 our data suggest that systolic indices do not differ between the 2 shunt types at 6 years. When comparing the shunt groups with respect to within-patient interval changes between the pre-Fontan and 6-year studies, RVEF and FAC both significantly increased in the RVPAS compared with the MBTS group, reversing the trend seen between 14 months and the pre-Fontan studies for the RVPAS. 7 For the entire cohort from the pre-Fontan study to 6 years, indexed RV volumes/areas declined and RVEF and FAC improved, suggesting beneficial remodeling during this time period. Diastolic indices also improved for the cohort compared with the 14-month and preFontan study, although it is important to recognize that Doppler-derived filling indices, particularly E/A ratio and E/E′, have little supporting validation in the Fontan group when compared with normative data from children with a biventricular circulation.
The reasons for improvement in RV systolic function in the RVPAS group after Fontan are not clear. Follow-up studies of the SVR cohort, focusing on outcomes at 3 years 4 and 6 years, 5 show no significant differences in transplant-free survival at those ages between the 2 shunt groups. Of note, the RVPAS group had a lower hazard of death or transplant up until the stage II procedure, after which the shunt effect on transplant-free survival was not significant. However, the RVPAS group had a somewhat higher hazard from stage II until the From the pre-Fontan to the 6-y echocardiogram, both ejection fraction and fractional area change significantly increased in the RVPAS when compared with the interval change in the MBTS group. Ejection fraction and fractional area change were similar for both shunt groups when comparing the 14-mo and 6-y studies. There was a significant decrease in both the end-diastolic volume and area from the pre-Fontan to the 6-y echocardiogram. End-diastolic volume was also decreased when comparing the 14-mo and 6-y studies, but end-diastolic areas were similar. BSA indicates body surface area.
Fontan procedure, then a somewhat lower hazard of death or transplant after that procedure. These findings mirror changes in RVEF between the 2 groups, with a higher ejection fraction before stage II palliation in the RVPAS, 6 similar ejection fraction at 14 months, and worse RVEF before Fontan. 7 The RVPAS also had a significantly higher incidence of catheter-based interventions at both 3 years 4 (balloon angioplasty, stent, and coiling). It is possible that these more frequent interventions, when coupled with the anticipated improvement in systemic oxygen saturations after Fontan, may have significantly lessened the hemodynamic burden for the RV in the RVPAS subjects, with a resultant improvement in RVEF.
Similarly, the neoaortic and tricuspid valves also showed no signs of significant deterioration at 6 years. It was interesting to note that despite having increased neoaortic valve size, our cohort had appropriate rate of growth in annulus size over time with little clinically significant valve dysfunction. The same was true for the tricuspid valve. Although other studies have shown progressive valve dysfunction in older children, our study suggests that at these ages, the valves can function well in the systemic circulation. Neoaortic valve size and integrity are critical to this cohort over time, given reports of significant neoaortic root dilatation [22] [23] [24] and neoaortic valve regurgitation 25 later in childhood after Norwood palliation. Our findings are consistent with a honeymoon period for both cardiac valves during early childhood in survivors with single RV anomalies after completion of staged surgical palliations.
We found that, independent of shunt type, poor RV systolic function at 14 months using RVEF or FAC was predictive of late death/transplant. Indeed, the hazard of late death/transplant when RVEF was <40% was tripled. This risk of a worse outcome with poorer RV function as identified using these systolic indices should warrant closer surveillance/consideration for increased supportive therapies because these findings are consistent with previous reports that identified impaired RV systolic function after stage II palliation as a risk factor for later death/need for transplantation. 25, 26 
STUDY LIMITATIONS
Our analyses of changes in echocardiographic parameters between 14 months and 6 years were performed among patients who survived to at least 6 years of age. These findings thus could be subject to survivor bias. This limitation was not true, however, for the assessment of the effect of 14-month RVEF on transplant-free survival because we did not require that subjects survive to later studies to be included in that analysis. Unlike the left ventricle, 2-dimensional echocardiographic tools used to assess RV volume and systolic function are limited by the chamber's complex geometry. Analysis of regional RV wall motion was not performed as part of this protocol because of limited frame rates used for image capture and poor characterization of RV circumferential motion, so the impact of focal scarring/dyskinesis was not specifically assessed; deformation techniques to assess RV function may provide additional information about risk of adverse outcomes. 27 Careful training in protocol image acquisition was provided and reinforced at all sites; however, the 6-year studies were performed as part of routine clinical care and thus submitted not only by participating Pediatric Heart Network sites but also by local cardiologists providing clinical care. Image acquisition was inadequate to achieve all measurements in the majority of studies. In particular, this limitation impacted the characterization of RV function, as seen in the low rate of measurable RVEF for the cohort, because the imaging necessary to calculate RVEF is difficult to obtain in this age group even in the most skilled hands. Because of this small sample size, we were unable to identify specific risk factors for reduced systolic The annular Z score decreased significantly for both the neoaortic and tricuspid valves between 14 mo and 6 y for the cohort with no differences in either valve Z score between pre-Fontan and 6-y studies. BSA indicates body surface area.
RV function or more than mild tricuspid regurgitation within subgroups of age and shunt type. To optimize assessments of RV function going forward, continued follow-up in this cohort now underway at age 10 to 12 years includes a cardiac magnetic resonance imaging.
CONCLUSIONS
Among survivors of staged palliation for single RV anomalies at 6 years in the SVR trial, initial surgical shunt type does not impact echocardiogram-derived indices of RV size and function. Beneficial remodeling of RV size, systolic and diastolic function, and neoaortic and tricuspid size are apparent over time, without progressive valvular regurgitation during early childhood. Poor RV systolic function at 14 months predicts worse late survival/need for cardiac transplantation independent of the initial shunt type.
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